Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Abbott Laboratories
| Okres |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
44,655.37 |
48,065.25 |
51,644.70 |
55,546.76 |
59,861.00 |
| Przychód Δ r/r |
0.00% |
7.64% |
7.45% |
7.56% |
7.77% |
| Przychód (min) |
44,514.41 |
47,620.11 |
51,608.71 |
54,914.02 |
59,179.12 |
| Przychód (max) |
45,279.64 |
49,107.29 |
51,680.68 |
56,491.04 |
60,878.63 |
| EBITDA (średnia) |
12,110.83 |
13,035.61 |
14,006.38 |
15,064.64 |
16,234.70 |
| EBIT (średnia) |
8,443.06 |
9,087.77 |
9,764.54 |
10,502.31 |
11,318.01 |
| EBIT % |
18.91% |
18.91% |
18.91% |
18.91% |
18.91% |
| Zysk netto (średni) |
9,020.68 |
10,129.19 |
11,056.20 |
12,044.09 |
13,232.36 |
| Zysk netto % |
20.20% |
21.07% |
21.41% |
21.68% |
22.11% |
| EPS (średnia) |
5.16 |
5.69 |
6.28 |
6.89 |
7.57 |
| Liczba analityków (Przychody) |
17 |
20 |
21 |
18 |
10 |
| Liczba analityków (EPS) |
18 |
17 |
11 |
5 |
4 |
| symbol |
ABT |
ABT |
ABT |
ABT |
ABT |